4/15
04:28 pm
crdf
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer [Yahoo! Finance]
Medium
Report
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer [Yahoo! Finance]
4/15
04:10 pm
crdf
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
4/15
04:05 pm
crdf
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer
Medium
Report
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer
3/1
08:48 am
crdf
Cardiff Oncology Full Year 2024 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
Cardiff Oncology Full Year 2024 Earnings: Beats Expectations [Yahoo! Finance]
2/28
08:13 am
crdf
Cardiff Oncology, Inc. (NASDAQ: CRDF) had its price target raised by analysts at HC Wainwright from $13.00 to $17.00. They now have a "buy" rating on the stock.
High
Report
Cardiff Oncology, Inc. (NASDAQ: CRDF) had its price target raised by analysts at HC Wainwright from $13.00 to $17.00. They now have a "buy" rating on the stock.
2/27
05:49 pm
crdf
Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update [Yahoo! Finance]
2/27
04:05 pm
crdf
Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
Medium
Report
Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
2/24
04:05 pm
crdf
Cardiff Oncology to Present at Upcoming Investor Conferences
Medium
Report
Cardiff Oncology to Present at Upcoming Investor Conferences
2/20
04:05 pm
crdf
Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update
Low
Report
Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update